Studies suggest that TonEBP upregulation is associated with many inflammatory diseases, including rheumatoid arthritis, atherosclerosis, seizures, lipopolysaccharide-injected brain injury, and diabetes18, 24–26. This evidence concerns the gene NFAT5 and rheumatoid arthritis.